VitaNova Life Sciences Corp
VNOV· OTC
VNOVVitaNova Life Sciences Corp
Filed Dec 6, 2019 · 10-Q · 36 days after period end · 0001683168-19-003897
| Metric | Q2 2020 | Q2 2019 | Q2 2018 |
|---|---|---|---|
| Revenue | $0.00 | — | — |
| Net Income | -$19.52K | -$40.05K | $5.78K |
| EPS Diluted | $0.00 | — | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
VitaNova Life Sciences Corp · CIK 1699709 · Engraved from SEC EDGAR
ended Oct 31, 2019 · filed Dec 6, 2019 · 36 d after period end
